Manufacturer record

Swift Life Sciences Pvt. Ltd: regulatory record

Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

4 batches manufactured by Swift Life Sciences Pvt. Ltd (Uttarakhand) were declared Not of Standard Quality between July 2024 and October 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Records by type

4 records linked to Swift Life Sciences Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
4Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Jul 2024 to Oct 2025

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

4
NSQ batches since 2024
4
Products affected
Labelling
Most common failure
Oct 2025
Latest alert

Flagged batches per year

2024 · 12025 · 3

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
DENOCK N SLTC24010Mfg 2024-03 · Exp 2026-02 The content of Naloxone found to be 0.1169 mg per tablet (116.9%) labelled claim of 0.1mg per tabletLabelling SDTL, PunjabState lab Oct 2025
Buprenorphine and Naloxone Sublingual Tablets I.P. 2mg+0.5mg ( (Akknck-N)) SLTG25022Mfg 2025-07 · Exp 2027-06 ContentOther SDTL, PunjabState lab Oct 2025
BUPERA N LITE SLTE25016Mfg 2025-05 · Exp 2027-04 The content of Naloxone found to be 0.112mg/tablet (112%) against labelled claim of 0.1mg/tablet.Labelling SDTL, PunjabState lab Oct 2025
Oxalobacter, Lactobacillus & Bifidobacteriu m with FOS Capsules (OXASPUR) RHCE23001Mfg 2023-05 · Exp 2024-10 Assay of Oxalobacter Species & Bifidobacteriu m BifidumAssay CDL KolkataCDSCO lab Jul 2024

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.